{"meta":{"query_hash":"55965a6cf75c","filters":{"venue":"Asia-Pacific Journal of Clinical Oncology"},"cohort_total":31,"direct_labels_cover":1,"predictions_cover":31,"exported":31,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/55965a6cf75c","api":"https://metacan.xera.ac/api/v1/cohort?venue=Asia-Pacific+Journal+of+Clinical+Oncology"},"results":[{"id":"W1486211631","doi":"10.1111/ajco.12189","title":"Preparing for tomorrow: Molecular diagnostics and the changing nonsmall cell lung cancer landscape","year":2014,"lang":"en","type":"review","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Pfizer","keywords":"Anaplastic lymphoma kinase; Medicine; Lung cancer; Targeted therapy; Cancer; Oncology; Identification (biology); Precision medicine; Chemotherapy; Internal medicine; Bioinformatics; Intensive care medicine; Cancer research; Pathology; Biology","score_opus":0.04746569454896561,"score_gpt":0.48354004033448117,"score_spread":0.43607434578551557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1486211631","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003989658,0.9981013,0.000053037722,0.0009988,0.00029023289,0.0000014647061,0.000005102439,0.0000037515504,0.0005064458],"genre_scores_gemma":[0.0003934907,0.9981565,0.00010181073,0.00067557604,0.0002859497,0.0000025084912,0.00001108778,0.0000012719169,0.00037189494],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996902,0.000074887386,0.00003797356,0.000040285526,0.00012686751,0.000029707318],"domain_scores_gemma":[0.99917245,0.000423305,0.00008781377,0.00001976527,0.00023372473,0.00006297976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093775365,0.0006861443,0.0010561831,0.0027226345,0.00045719062,0.0013552997,0.0009327519,0.0018683617,0.0030540032],"category_scores_gemma":[0.0017012982,0.00027235213,0.0005461294,0.002311755,0.0008377583,0.0027744316,0.0007713454,0.0029720468,0.0020079613],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034626268,0.000045074463,0.00021022503,0.009835076,0.000055071552,0.00019248386,0.0001087899,0.0002523141,0.0005253288,0.0056073,0.06826087,0.9148728],"study_design_scores_gemma":[0.0000073971555,0.000041202264,0.00064343435,0.0044454318,0.00004283957,0.0012236199,0.00012438912,0.0000499284,0.00014292268,0.0032796569,0.98998356,0.000015537958],"about_ca_topic_score_codex":0.0018573622,"about_ca_topic_score_gemma":0.0034889788,"teacher_disagreement_score":0.0030540032,"about_ca_system_score_codex":0.0012217154,"about_ca_system_score_gemma":0.001730325,"threshold_uncertainty_score":0.010216653},"labels":[],"label_agreement":null},{"id":"W1572964200","doi":"10.1111/ajco.12190","title":"<scp>N</scp>ational <scp>W</scp>orking <scp>G</scp>roup <scp>M</scp>eeting on <scp>ALK</scp> diagnostics in lung cancer","year":2014,"lang":"en","type":"article","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Comprehensive Cancer Network; Royal College of Pathologists of Australasia; Pfizer","keywords":"Lung cancer; Medicine; Cancer research; Oncology","score_opus":0.04332227479013119,"score_gpt":0.4227194851432604,"score_spread":0.37939721035312923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1572964200","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019375594,0.0442649,0.0040337243,0.14179626,0.012821679,0.00027503056,0.0031635347,0.00078289764,0.7734864],"genre_scores_gemma":[0.2416209,0.09333039,0.008965171,0.046713434,0.023455575,0.00025346482,0.0054356963,0.0006001088,0.57962525],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994585,0.00014206658,0.00004461813,0.000047043737,0.00023146356,0.000076336815],"domain_scores_gemma":[0.9986914,0.00033249252,0.0001445761,0.000053403295,0.00042153226,0.00035660408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006558492,0.00025774998,0.00026843447,0.00096018176,0.0005550478,0.0009793213,0.00036267252,0.0009373141,0.07269957],"category_scores_gemma":[0.0021268912,0.00010770321,0.0002682615,0.00077917933,0.0005787105,0.0005216149,0.00060470676,0.001001385,0.024779141],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008924041,0.000045258537,0.0049494714,0.0002595347,0.000011205413,0.00052651187,0.00005235352,0.0002162362,0.0016668901,0.0018008425,0.72350955,0.26687288],"study_design_scores_gemma":[0.000020690402,0.00006460287,0.009151838,0.00021050198,0.000010229313,0.001901765,0.00009567583,0.0001757028,0.0018995373,0.0014110968,0.98504907,0.000009275532],"about_ca_topic_score_codex":0.0031808608,"about_ca_topic_score_gemma":0.013078802,"teacher_disagreement_score":0.07269957,"about_ca_system_score_codex":0.0011845925,"about_ca_system_score_gemma":0.0016885118,"threshold_uncertainty_score":0.2432043},"labels":[],"label_agreement":null},{"id":"W1578512802","doi":"10.1111/ajco.12275","title":"Welcome Message from Conference Co‐Convenors","year":2014,"lang":"en","type":"article","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Theme (computing); Library science; Executive director; Officer; Political science; Media studies; Management; Sociology; Law","score_opus":0.0640635115139888,"score_gpt":0.40288290812288025,"score_spread":0.33881939660889143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1578512802","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006579673,0.004478547,0.0008363943,0.45218074,0.5282716,0.00042332048,0.00050761295,0.000500941,0.012142881],"genre_scores_gemma":[0.009105332,0.0035365408,0.0018331415,0.64933217,0.21309926,0.002342734,0.0008687478,0.00076058705,0.11912149],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98378897,0.004913836,0.00092004956,0.0018656937,0.005673707,0.0028377923],"domain_scores_gemma":[0.9025934,0.008074198,0.0035227905,0.002072469,0.029726528,0.05401069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016269453,0.002825645,0.001927526,0.0013005907,0.0057555763,0.012437904,0.0042304583,0.027088072,0.08367715],"category_scores_gemma":[0.06774394,0.00094162585,0.002735944,0.00080929726,0.0021467234,0.007124443,0.012517525,0.04030145,0.07240274],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007875256,0.00003739842,0.000112488015,0.00013357493,0.000008658128,0.00017916164,0.0001443525,0.00002673629,0.00013535493,0.00030497034,0.9922936,0.0065449695],"study_design_scores_gemma":[0.000066931374,0.00007069133,0.00041647296,0.00024876656,0.00001031571,0.00022940432,0.0011315553,0.00006815502,0.000111176065,0.000790528,0.9968041,0.000051767343],"about_ca_topic_score_codex":0.0015821515,"about_ca_topic_score_gemma":0.0033302864,"teacher_disagreement_score":0.08367715,"about_ca_system_score_codex":0.0041918526,"about_ca_system_score_gemma":0.011386604,"threshold_uncertainty_score":0.2799279},"labels":[],"label_agreement":null},{"id":"W1595251153","doi":"10.1111/j.1743-7563.2010.01328.x","title":"A phase II trial of weekly i.v. KW‐2170 in advanced castrate‐resistant prostate cancer","year":2010,"lang":"en","type":"article","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Medicine; Neutropenia; Prostate cancer; Internal medicine; Phases of clinical research; Nausea; Oncology; Chemotherapy; Cancer; Gastroenterology; Urology","score_opus":0.09392100312257858,"score_gpt":0.5098557369329367,"score_spread":0.41593473381035817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1595251153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951729,0.0012346909,0.00036668486,0.00021965963,0.00008467673,0.0014100908,0.00035801882,0.000087403656,0.0010658032],"genre_scores_gemma":[0.9919552,0.0012210108,0.001056675,0.00038971583,0.00013006885,0.0016715744,0.001080745,0.00002627126,0.002468776],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99965227,0.00018378298,0.000017198561,0.000049622282,0.000028506496,0.00006869243],"domain_scores_gemma":[0.99944776,0.00009718865,0.0001084193,0.000051402818,0.000028830791,0.0002664411],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010764155,0.0013090145,0.0014853764,0.0006072492,0.00042734903,0.00061648723,0.0009841435,0.0011228085,0.004263661],"category_scores_gemma":[0.00065309374,0.00053245283,0.0007943075,0.0004922098,0.000918212,0.00065183203,0.00034338428,0.002295543,0.00086051354],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.71204257,0.08798876,0.0042170365,0.0014697989,0.001087381,0.00036167828,0.00038767164,0.0036339296,0.054114167,0.0004297539,0.004227492,0.1300397],"study_design_scores_gemma":[0.52371866,0.46437192,0.0055267904,0.0000276251,0.00024112382,0.0002586156,0.0000484512,0.0010558168,0.0034141866,0.00013576027,0.0011779651,0.000023166005],"about_ca_topic_score_codex":0.00090767286,"about_ca_topic_score_gemma":0.001655858,"teacher_disagreement_score":0.004263661,"about_ca_system_score_codex":0.000577279,"about_ca_system_score_gemma":0.0010417158,"threshold_uncertainty_score":0.0142633915},"labels":[],"label_agreement":null},{"id":"W1706038533","doi":"10.1111/ajco.12064","title":"Comparison of the <scp>EORTC QLQ</scp>‐<scp>BM22</scp> and the <scp>BOMET‐QOL</scp> quality of life questionnaires in patients with bone metastases","year":2013,"lang":"en","type":"article","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Response Biomedical (Canada); Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Quality of life (healthcare); Medicine; Physical therapy; Reliability (semiconductor); Cancer; Internal medicine; Nursing","score_opus":0.06566616173151467,"score_gpt":0.402386003649203,"score_spread":0.33671984191768833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1706038533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75905675,0.22912022,0.0010618129,0.001436545,0.00035782007,0.0010742431,0.0031018073,0.000010172048,0.004780544],"genre_scores_gemma":[0.9697183,0.024068693,0.0012860947,0.0005489658,0.00016040882,0.0013313541,0.0026036117,0.000008167444,0.0002744838],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99094206,0.005244925,0.0015955621,0.00048670414,0.0015315716,0.00019915114],"domain_scores_gemma":[0.9706204,0.02258398,0.0037697211,0.00023088674,0.0023934343,0.0004016511],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011387952,0.0004496192,0.0017651806,0.0042793765,0.0002730458,0.0009986716,0.00066793675,0.0009796415,0.0018251592],"category_scores_gemma":[0.041897032,0.00028817204,0.0025752687,0.00451566,0.0004761354,0.0019462272,0.0009739724,0.00077718234,0.00019761511],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035649072,0.0015156196,0.5333715,0.06479464,0.042203598,0.0005205078,0.003199159,0.0015418512,0.0017017191,0.001187676,0.0044639437,0.30985072],"study_design_scores_gemma":[0.008080139,0.01362854,0.9375473,0.010067367,0.014446833,0.0012967711,0.003008913,0.0014325905,0.0005309649,0.00076685875,0.00904928,0.00014445792],"about_ca_topic_score_codex":0.0017730294,"about_ca_topic_score_gemma":0.0039040775,"teacher_disagreement_score":0.011387952,"about_ca_system_score_codex":0.0012274226,"about_ca_system_score_gemma":0.001415928,"threshold_uncertainty_score":0.060226023},"labels":[],"label_agreement":null},{"id":"W1944351704","doi":"10.1111/ajco.12069","title":"Minimal important differences in the <scp>EORTC QLQ</scp>‐<scp>C15</scp>‐<scp>PAL</scp> to determine meaningful change in palliative advanced cancer patients","year":2013,"lang":"en","type":"article","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Response Biomedical (Canada); Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Ofelia Cancer Research Fund; Michael and Karyn Goldstein Cancer Research Fund; Joseph and Silvana Melara Cancer Research Fund","keywords":"Medicine; Quality of life (healthcare); Clinical trial; Palliative care; Minimal clinically important difference; Cancer; Breast cancer; Lung cancer; Prostate cancer; Physical therapy; Oncology; Internal medicine; Randomized controlled trial","score_opus":0.08937025942784335,"score_gpt":0.39433845725742894,"score_spread":0.3049681978295856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1944351704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842391,0.0015197082,0.009318312,0.00024778,0.00009038691,0.0005248212,0.0013883733,0.00004201342,0.0026296605],"genre_scores_gemma":[0.99297863,0.00008021799,0.0054637888,0.000081793594,0.000016465086,0.0004973406,0.0006426648,0.000006472396,0.00023258378],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9948468,0.0028935994,0.0006393056,0.00023089442,0.001266109,0.0001232459],"domain_scores_gemma":[0.98970807,0.0058327033,0.0025363292,0.00045148324,0.0009801164,0.0004913468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007204943,0.000390209,0.00043209756,0.0008790788,0.00022594353,0.00044241536,0.0005305533,0.00031734386,0.0016840653],"category_scores_gemma":[0.020142209,0.00012139098,0.00080482225,0.00067080144,0.00031280902,0.00041114612,0.0008106341,0.00070631,0.0002339341],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009209691,0.0015723471,0.778011,0.00088797376,0.0014874733,0.00018896806,0.0010699497,0.0050996155,0.0071481634,0.0017860902,0.005945126,0.18759373],"study_design_scores_gemma":[0.0005952331,0.007889687,0.9713163,0.00011811996,0.00018705866,0.0004830938,0.0003287857,0.008720067,0.0033576463,0.0019513526,0.0049975733,0.000055025943],"about_ca_topic_score_codex":0.00034645555,"about_ca_topic_score_gemma":0.0008193194,"teacher_disagreement_score":0.007204943,"about_ca_system_score_codex":0.0004811032,"about_ca_system_score_gemma":0.00037227198,"threshold_uncertainty_score":0.03810388},"labels":[],"label_agreement":null},{"id":"W1962829821","doi":"10.1111/ajco.12070","title":"Minimal important differences in the <scp>EORTC QLQ‐C30</scp> in patients with advanced cancer","year":2013,"lang":"en","type":"article","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Response Biomedical (Canada); Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Quality of life (healthcare); Medicine; Cancer; Statistical significance; Sample size determination; Physical therapy; Clinical significance; Cognition; Internal medicine; Statistics; Psychiatry; Nursing","score_opus":0.03847075478638437,"score_gpt":0.3653413403519545,"score_spread":0.32687058556557014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1962829821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99678063,0.0007767899,0.0007639163,0.00030974808,0.000015647787,0.00005931297,0.00021906751,0.000010581563,0.0010643043],"genre_scores_gemma":[0.9992951,0.00006487967,0.0003982249,0.000045610774,0.000006847991,0.000032504973,0.0000960232,0.0000015659689,0.00005917911],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976895,0.0012696523,0.00024146812,0.0001687482,0.0005093238,0.000121387],"domain_scores_gemma":[0.9948637,0.0027382947,0.0014768892,0.0001586304,0.00038195835,0.00038047577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036897522,0.00018566425,0.00036935593,0.0005040464,0.00024511016,0.00040386655,0.00027842858,0.0003539287,0.00083538395],"category_scores_gemma":[0.0132078985,0.000089132,0.00037860087,0.0005955824,0.00035599255,0.00047890426,0.0006310621,0.00066552404,0.00012357945],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030561457,0.0006259138,0.86543876,0.0002731746,0.00025740103,0.00023952336,0.0015470197,0.002144529,0.0023141054,0.0003362589,0.0024137574,0.12135343],"study_design_scores_gemma":[0.00019613025,0.0026123691,0.99090844,0.00004008529,0.000054887896,0.0003494696,0.00045299146,0.0025325927,0.0007608357,0.00079443166,0.001274137,0.000023590605],"about_ca_topic_score_codex":0.00067445205,"about_ca_topic_score_gemma":0.0010501782,"teacher_disagreement_score":0.0036897522,"about_ca_system_score_codex":0.00043695103,"about_ca_system_score_gemma":0.00024700127,"threshold_uncertainty_score":0.019513488},"labels":[],"label_agreement":null},{"id":"W2440371401","doi":"10.1111/ajco.12513","title":"An East Asian subgroup analysis of PROCLAIM, a phase III trial of pemetrexed and cisplatin or etoposide and cisplatin plus thoracic radiation therapy followed by consolidation chemotherapy in locally advanced nonsquamous non–small cell lung cancer","year":2016,"lang":"en","type":"article","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"Eli Lilly and Company","keywords":"Pemetrexed; Medicine; Cisplatin; Hazard ratio; Etoposide; Internal medicine; Oncology; Carboplatin; Chemotherapy; Confidence interval; Surgery","score_opus":0.034623184524547664,"score_gpt":0.4324831263084926,"score_spread":0.39785994178394496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2440371401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98930025,0.0074349088,0.00062254723,0.0003025229,0.0001609119,0.00057463365,0.0007288699,0.00002318903,0.00085228967],"genre_scores_gemma":[0.99562824,0.0013045876,0.0005855778,0.0005088462,0.000112624,0.00047775861,0.00070969417,0.000013056098,0.0006596556],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99845994,0.00084048556,0.00024359868,0.00020999399,0.000109807326,0.00013611736],"domain_scores_gemma":[0.99875236,0.00033394096,0.00034279417,0.00027631925,0.00012582619,0.00016875824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047631613,0.0011894102,0.0022069844,0.00043268345,0.00032723937,0.0008630917,0.00043748578,0.00068967364,0.0018943578],"category_scores_gemma":[0.0024535193,0.00032831496,0.0066641383,0.0005635193,0.00037360072,0.0005128329,0.00045687237,0.0011404234,0.0002172008],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.81505466,0.0013533457,0.0529362,0.0026676862,0.07627568,0.00038117735,0.0003383606,0.0012929112,0.00973448,0.00028670087,0.0017631362,0.03791576],"study_design_scores_gemma":[0.4176286,0.06682495,0.18434936,0.00047681117,0.30866998,0.00083026005,0.0007668244,0.004185985,0.008867986,0.0010637899,0.006185626,0.00014987878],"about_ca_topic_score_codex":0.0010236552,"about_ca_topic_score_gemma":0.0037372378,"teacher_disagreement_score":0.0047631613,"about_ca_system_score_codex":0.00061879243,"about_ca_system_score_gemma":0.0011518191,"threshold_uncertainty_score":0.025190294},"labels":[],"label_agreement":null},{"id":"W2531395888","doi":"10.1111/ajco.12524","title":"Convenor's Welcome","year":2016,"lang":"en","type":"article","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Mentorship; Medical education; Oncology; Library science","score_opus":0.08744800783826183,"score_gpt":0.43538723783270594,"score_spread":0.3479392299944441,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531395888","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000725381,0.0035576858,0.0023982327,0.17702341,0.6732114,0.0011865848,0.0020950201,0.0017548924,0.1380473],"genre_scores_gemma":[0.0051505645,0.0021962728,0.0025543543,0.0958673,0.13344404,0.0017601729,0.0023432095,0.0016391337,0.75504494],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9929219,0.0012972236,0.00035046003,0.0011371588,0.003021624,0.0012716999],"domain_scores_gemma":[0.9691051,0.002009256,0.0007607574,0.001151792,0.010492008,0.016481077],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008195368,0.0021270805,0.0013243544,0.0014252376,0.0042631202,0.008883392,0.0032900744,0.01009374,0.4009788],"category_scores_gemma":[0.029456632,0.0007395769,0.0016522611,0.00064228015,0.001084916,0.0039776447,0.009693693,0.011773337,0.2660027],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028403423,0.0000160183,0.000031204698,0.00006694399,0.0000020597909,0.00007497434,0.000052674885,0.000018789171,0.00017546526,0.0006024936,0.9883996,0.010531276],"study_design_scores_gemma":[0.000015450603,0.000022605142,0.00009235013,0.000060096696,0.000001437478,0.00004917839,0.00015045589,0.000021613569,0.00003656273,0.0005279633,0.99901557,0.0000067740248],"about_ca_topic_score_codex":0.0016257633,"about_ca_topic_score_gemma":0.0038868408,"teacher_disagreement_score":0.4009788,"about_ca_system_score_codex":0.002598695,"about_ca_system_score_gemma":0.008967579,"threshold_uncertainty_score":0.85443103},"labels":[],"label_agreement":null},{"id":"W2588872717","doi":"10.1111/ajco.12670","title":"Sunrise in melanoma management: Time to focus on melanoma burden in Asia","year":2017,"lang":"en","type":"article","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Melanoma; Focus (optics); Sunrise; Geography; Medicine; Cancer research; Meteorology","score_opus":0.04609936240638862,"score_gpt":0.3855619401874746,"score_spread":0.33946257778108596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588872717","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02548143,0.5354016,0.0018861704,0.4003945,0.010324423,0.0001394858,0.00026513965,0.00021552618,0.025891874],"genre_scores_gemma":[0.301948,0.5611297,0.005919011,0.0969571,0.023247885,0.00034504762,0.00077947753,0.00019662884,0.009477225],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99864906,0.0005408178,0.00016021587,0.00011358232,0.00029319103,0.00024306415],"domain_scores_gemma":[0.9957106,0.0008447761,0.00051947037,0.0000721025,0.00097130303,0.0018817954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003683862,0.00041749043,0.0009946892,0.0008290653,0.0014075421,0.0031272394,0.0012452892,0.0018744378,0.011467483],"category_scores_gemma":[0.00853444,0.00029790364,0.00063468475,0.0007160587,0.0007079084,0.0047134785,0.002805351,0.0049255807,0.0014975865],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038095744,0.00045217993,0.026269251,0.0035702162,0.000114706105,0.0013824966,0.0021838297,0.00056773704,0.00061416085,0.0040117316,0.22830386,0.7321489],"study_design_scores_gemma":[0.00030027184,0.0012498192,0.10998569,0.034955364,0.00034502015,0.006005085,0.018844932,0.0012763039,0.0009066418,0.016624823,0.80928576,0.00022029105],"about_ca_topic_score_codex":0.008941774,"about_ca_topic_score_gemma":0.02388413,"teacher_disagreement_score":0.011467483,"about_ca_system_score_codex":0.0030923998,"about_ca_system_score_gemma":0.008135795,"threshold_uncertainty_score":0.038362563},"labels":[],"label_agreement":null},{"id":"W2789982459","doi":"10.1111/ajco.12855","title":"Cultural adaptation and validation of the Chinese version of the expanded prostate cancer index composite","year":2018,"lang":"en","type":"article","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Simon Fraser University; BC Cancer Agency","funders":"","keywords":"Adaptation (eye); Prostate cancer; Index (typography); Composite index; Composite number; Cancer; Psychology; Medicine; Computer science; Mathematics; Internal medicine; Composite indicator; Econometrics; Neuroscience; Algorithm; World Wide Web","score_opus":0.05417021280253508,"score_gpt":0.4141333786232248,"score_spread":0.3599631658206897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789982459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98291343,0.00029353047,0.0060647395,0.00038069146,0.00018757519,0.0046792775,0.0008576569,0.000043229484,0.0045798575],"genre_scores_gemma":[0.9349068,0.0006682046,0.04803475,0.00046590448,0.00007212427,0.010663048,0.0025538092,0.00006212261,0.002573412],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9948566,0.0026271988,0.00072096474,0.00040436347,0.0011550181,0.00023588359],"domain_scores_gemma":[0.9932166,0.0013038642,0.0003973718,0.0008956881,0.003940263,0.00024629367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015208755,0.0005359757,0.0003139874,0.00081414706,0.0010390398,0.0005376022,0.00086854934,0.00027320205,0.0019068788],"category_scores_gemma":[0.019558163,0.00026496517,0.00090566743,0.0008483135,0.00077553844,0.00051022775,0.0015812125,0.000803722,0.00032773236],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018371891,0.0024129876,0.41931862,0.0015502985,0.00040531027,0.0018235979,0.08138963,0.0017682033,0.02622148,0.003431765,0.014769163,0.44507185],"study_design_scores_gemma":[0.0006457591,0.0038854259,0.93295956,0.0006699509,0.000352314,0.0015131437,0.013641489,0.003368855,0.008459154,0.0010616658,0.033237424,0.00020522943],"about_ca_topic_score_codex":0.0073795426,"about_ca_topic_score_gemma":0.010438869,"teacher_disagreement_score":0.015208755,"about_ca_system_score_codex":0.0009924448,"about_ca_system_score_gemma":0.0033086939,"threshold_uncertainty_score":0.080432534},"labels":[],"label_agreement":null},{"id":"W2895166167","doi":"10.1111/ajco.13065","title":"Emerging data and future directions for CDK4/6 inhibitor treatment of patients with hormone receptor positive HER2‐non‐amplified metastatic breast cancer","year":2018,"lang":"en","type":"article","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nutrasource","funders":"","keywords":"Metastatic breast cancer; Breast cancer; Cyclin-dependent kinase 4; Palbociclib; Medicine; Context (archaeology); Oncology; Hormone receptor; Cancer; Internal medicine; Human Epidermal Growth Factor Receptor 2; Endocrine system; Cancer research; Hormone; Cell cycle; Biology; Cyclin-dependent kinase 2","score_opus":0.04894483337038611,"score_gpt":0.4177188545871236,"score_spread":0.36877402121673747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2895166167","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017034084,0.9785786,0.0005404226,0.01552659,0.0005859072,0.000023270644,0.00016328403,0.00003806707,0.0028404114],"genre_scores_gemma":[0.01158539,0.9767571,0.0017764687,0.0069953217,0.0016784185,0.00006165418,0.00029831837,0.00001708079,0.00083032885],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992606,0.0002598812,0.00014760677,0.000096011456,0.00016725688,0.000068608446],"domain_scores_gemma":[0.9947344,0.003045854,0.0007261994,0.000115534225,0.001040001,0.00033806788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035272175,0.0005391984,0.0014266308,0.0010740785,0.00028811954,0.0020468642,0.000984165,0.0015070508,0.0073154997],"category_scores_gemma":[0.004126037,0.00024725575,0.0013943028,0.0012024988,0.0007908477,0.0029914803,0.0006270957,0.003506658,0.0016908314],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011317114,0.00029200027,0.0020991352,0.008443617,0.0002516482,0.00029074203,0.000115991825,0.00074271805,0.0020862021,0.005536992,0.028754693,0.95025456],"study_design_scores_gemma":[0.0007544804,0.003284427,0.009817054,0.016849231,0.0019264423,0.0020679676,0.00064115087,0.0017632223,0.002242203,0.016144833,0.94441706,0.00009195056],"about_ca_topic_score_codex":0.0010870338,"about_ca_topic_score_gemma":0.0037809701,"teacher_disagreement_score":0.0073154997,"about_ca_system_score_codex":0.0009976565,"about_ca_system_score_gemma":0.0021295727,"threshold_uncertainty_score":0.024472713},"labels":[],"label_agreement":null},{"id":"W2895682835","doi":"10.1111/ajco.13064","title":"Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm","year":2018,"lang":"en","type":"article","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nutrasource","funders":"Novartis Australia","keywords":"Metastatic breast cancer; Tolerability; Medicine; Oncology; Breast cancer; Internal medicine; Endocrine system; Hormone receptor; Cyclin-dependent kinase; Hormone; Cancer; Cell cycle; Adverse effect","score_opus":0.07353694004946239,"score_gpt":0.4576646807170495,"score_spread":0.38412774066758715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2895682835","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011402437,0.9937312,0.00020515455,0.0029640603,0.00014873703,0.0000061798473,0.00001788522,0.0000055422056,0.0017810263],"genre_scores_gemma":[0.008676023,0.9888626,0.0005015516,0.0012627296,0.00026154498,0.000010079731,0.000029844956,0.000003763332,0.00039187062],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994955,0.00017535199,0.000084065265,0.00007017683,0.00013790141,0.00003694576],"domain_scores_gemma":[0.99915063,0.00046855124,0.00015889971,0.000020708654,0.00015909957,0.000042080308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018580449,0.00031190403,0.0009730328,0.0005897206,0.00023011366,0.0011225819,0.000597691,0.0004806556,0.0020322583],"category_scores_gemma":[0.0014738686,0.00015873804,0.0005587238,0.00063471834,0.00052024197,0.0016198786,0.00047401854,0.0018205687,0.00048467764],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042585057,0.000064889915,0.0005896695,0.009496902,0.00012454746,0.0003491127,0.00011168675,0.0005921993,0.0023410104,0.0048431307,0.013121719,0.96793926],"study_design_scores_gemma":[0.00021533118,0.0010433306,0.0038276718,0.009829341,0.00054330943,0.0038791879,0.00026696443,0.00054016366,0.0022130935,0.0072034905,0.97039247,0.000045589455],"about_ca_topic_score_codex":0.0010997091,"about_ca_topic_score_gemma":0.004577815,"teacher_disagreement_score":0.0020322583,"about_ca_system_score_codex":0.0007990911,"about_ca_system_score_gemma":0.0012720483,"threshold_uncertainty_score":0.009826362},"labels":[],"label_agreement":null},{"id":"W2902348306","doi":"10.1111/ajco.13059","title":"Prime time for immunotherapy in advanced urothelial cancer","year":2018,"lang":"en","type":"review","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Pembrolizumab; Carboplatin; Oncology; Internal medicine; Clinical trial; Chemotherapy; Disease; Cisplatin; Immunotherapy; Cancer; Intensive care medicine","score_opus":0.13085102567069737,"score_gpt":0.5175727264392097,"score_spread":0.3867217007685123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902348306","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014567187,0.9624207,0.00076286105,0.018331265,0.0044978186,0.00008637801,0.0005594584,0.00003748847,0.011847253],"genre_scores_gemma":[0.030077627,0.92897326,0.0031968951,0.019845512,0.008397777,0.00025167744,0.0013261249,0.000046293982,0.007884765],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986438,0.0006253177,0.00016384089,0.00011726366,0.0003785,0.000071360046],"domain_scores_gemma":[0.9965988,0.0018081522,0.0007701319,0.000091285896,0.0004477999,0.00028399524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003179641,0.00030792973,0.0006466312,0.0013424987,0.00034152274,0.0020799034,0.0006010643,0.0012647177,0.02389831],"category_scores_gemma":[0.0046966,0.000120994926,0.0008812765,0.0014980835,0.00035745013,0.0024256157,0.0009420943,0.0017942591,0.0029646421],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004286381,0.00008702915,0.0013194003,0.047668524,0.00025349073,0.00024961168,0.0002024608,0.0001669366,0.0015013788,0.008834745,0.15391406,0.7853737],"study_design_scores_gemma":[0.00008869521,0.0002584056,0.0014508405,0.015767466,0.00026672982,0.0006746485,0.000166145,0.000060315186,0.0003937157,0.0041446113,0.9767181,0.000010279188],"about_ca_topic_score_codex":0.00022989434,"about_ca_topic_score_gemma":0.0006724368,"teacher_disagreement_score":0.02389831,"about_ca_system_score_codex":0.0006739801,"about_ca_system_score_gemma":0.0020646055,"threshold_uncertainty_score":0.07994777},"labels":[],"label_agreement":null},{"id":"W2914899520","doi":"10.1111/ajco.13135","title":"Right versus left sided metastatic colorectal cancer: Teasing out clinicopathologic drivers of disparity in survival","year":2019,"lang":"en","type":"article","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Splenic flexure; Colorectal cancer; Hazard ratio; Internal medicine; Oncology; Primary tumor; Multivariate analysis; Chemotherapy; Proportional hazards model; Population; Cancer; Gastroenterology; Metastasis; Surgery; Confidence interval","score_opus":0.10361658283080687,"score_gpt":0.45146860513460185,"score_spread":0.34785202230379497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914899520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99846715,0.0006052062,0.00014495707,0.00017121134,0.000009208934,0.0000050312833,0.00019040897,0.0000025647385,0.00040421044],"genre_scores_gemma":[0.9997502,0.000053359316,0.000037211747,0.000015232267,0.000016578319,0.0000019881775,0.00009614318,0.0000016585536,0.000027657486],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99921703,0.00029367465,0.000055411496,0.00018623444,0.00007399527,0.00017365979],"domain_scores_gemma":[0.99625105,0.001354914,0.0013819068,0.00038601697,0.00020889634,0.0004172211],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018910329,0.00017682133,0.00034021374,0.00078653934,0.0002999782,0.00070238893,0.00044267948,0.00039296655,0.0018402684],"category_scores_gemma":[0.005164303,0.00013414561,0.0005333727,0.00094102003,0.00050438836,0.0008324438,0.00069765205,0.0006778102,0.00021062323],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024076486,0.0000136968565,0.99750745,0.0000081955695,0.000050614934,0.000046714253,0.00006744736,0.000054259493,0.0001865625,0.00010639595,0.0001102838,0.0016077027],"study_design_scores_gemma":[0.000008649723,0.000091863345,0.99774015,0.000010830752,0.000061504565,0.00026807276,0.00040230688,0.00075187493,0.00011490149,0.00023911061,0.00030596013,0.000004923578],"about_ca_topic_score_codex":0.0013113905,"about_ca_topic_score_gemma":0.0021479987,"teacher_disagreement_score":0.0018910329,"about_ca_system_score_codex":0.00031633224,"about_ca_system_score_gemma":0.0003714366,"threshold_uncertainty_score":0.010000825},"labels":[],"label_agreement":null},{"id":"W2920920710","doi":"10.1111/ajco.13116","title":"<i>BRCA</i> mutation testing for ovarian cancer in the context of available targeted therapy: Survey and consensus of Hong Kong specialists","year":2019,"lang":"en","type":"article","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Willow Breast and Hereditary Cancer Support","funders":"AstraZeneca","keywords":"Genetic testing; Medicine; Context (archaeology); Genetic counseling; Family medicine; BRCA mutation; Personalized medicine; Guideline; Delphi method; Breast cancer; Cancer; Bioinformatics; Internal medicine; Pathology; Genetics","score_opus":0.10005522970071315,"score_gpt":0.39378878930626904,"score_spread":0.2937335596055559,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2920920710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99842715,0.00025645405,0.00006823032,0.0003765448,0.00000849616,0.00003945725,0.00007985305,0.0000015804875,0.000742308],"genre_scores_gemma":[0.9986779,0.00040980236,0.00017075727,0.0003250875,0.00000533374,0.00003267019,0.00006611188,0.000001316193,0.0003109488],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.99822086,0.0007434903,0.00031466398,0.00014669493,0.00021990247,0.00035437243],"domain_scores_gemma":[0.99461985,0.0017034861,0.0011548497,0.00016007776,0.0015059557,0.0008557358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037135864,0.0001736077,0.0002676438,0.0005943182,0.0008481555,0.0007671936,0.0003339728,0.00043808357,0.0013337485],"category_scores_gemma":[0.0058509037,0.00023913788,0.00036118025,0.00073309557,0.0006366064,0.0004899211,0.0010240917,0.0003211183,0.00019019321],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009452558,0.000059196052,0.9538589,0.00031277942,0.000041023308,0.0010698743,0.032206263,0.0000943658,0.0009075832,0.00006091319,0.0013463481,0.009948289],"study_design_scores_gemma":[0.000018136863,0.0002661989,0.85286295,0.0002714816,0.000048267466,0.0008395804,0.1406885,0.0006074144,0.0003207492,0.000034823024,0.004008731,0.00003324719],"about_ca_topic_score_codex":0.07216964,"about_ca_topic_score_gemma":0.062083587,"teacher_disagreement_score":0.07216964,"about_ca_system_score_codex":0.0020034744,"about_ca_system_score_gemma":0.0029321944,"threshold_uncertainty_score":0.14349914},"labels":[],"label_agreement":null},{"id":"W2958441110","doi":"10.1111/ajco.13181","title":"Viable versus nonviable positive margins in Ewing sarcoma and associated recurrence rates: A systematic review","year":2019,"lang":"en","type":"review","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa","funders":"","keywords":"Medicine; Margin (machine learning); Sarcoma; Surgical margin; Radiation therapy; Histology; Resection margin; Surgery; Soft tissue sarcoma; Radiology; Resection; Pathology","score_opus":0.19598565200160228,"score_gpt":0.49209004024854414,"score_spread":0.29610438824694185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2958441110","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001114483,0.9979532,0.000078247125,0.00011164952,0.000054873726,0.00015352221,0.00035173152,0.0000056215986,0.00017669672],"genre_scores_gemma":[0.012239102,0.9865165,0.00029428295,0.00025900654,0.00004999907,0.00028263908,0.00022067275,0.0000041232443,0.00013374578],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9966799,0.0008710577,0.0014537801,0.00027632818,0.00060008507,0.00011879469],"domain_scores_gemma":[0.9841591,0.011445104,0.0029341571,0.00015475965,0.0011495833,0.00015720351],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004441659,0.0011424685,0.006845897,0.009471002,0.00044446447,0.0020246916,0.0012275138,0.0014467405,0.0045342995],"category_scores_gemma":[0.020234143,0.0007902047,0.0069690146,0.010694196,0.0006480937,0.0018716466,0.0011187674,0.0008184887,0.00034166308],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018065429,0.000011029676,0.00085575506,0.96814483,0.0078026955,0.000081077174,0.000109183915,0.00006290597,0.000120989935,0.000108472566,0.00093983836,0.02158257],"study_design_scores_gemma":[0.00026198206,0.00024277373,0.007264178,0.8468827,0.12731786,0.0005844013,0.00027650537,0.00009898019,0.00020790088,0.00026066817,0.016559154,0.000042876436],"about_ca_topic_score_codex":0.0066851396,"about_ca_topic_score_gemma":0.022769121,"teacher_disagreement_score":0.009471002,"about_ca_system_score_codex":0.0022829683,"about_ca_system_score_gemma":0.0061571747,"threshold_uncertainty_score":0.023490071},"labels":[],"label_agreement":null},{"id":"W2971814790","doi":"10.1111/ajco.13234","title":"Impact of Asian ethnicity on outcome in metastatic EGFR‐mutant non–small cell lung cancer","year":2019,"lang":"en","type":"article","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Calgary","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; Brain metastasis; Lung cancer; Oncology; Univariate analysis; Cohort; Proportional hazards model; Cancer; Population; Metastasis; Multivariate analysis; Confidence interval","score_opus":0.07858565461785147,"score_gpt":0.5110388023357402,"score_spread":0.4324531477178887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971814790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992926,0.00013665015,0.00004166803,0.000033005064,0.0000046555715,0.0000017987211,0.00017968679,0.0000015893031,0.00030835462],"genre_scores_gemma":[0.99975234,0.00004063334,0.000013855101,0.000008250835,0.0000036319861,0.000001051206,0.000120488054,8.8717263e-7,0.000058961814],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997701,0.000064529195,0.000033640976,0.00004434341,0.00003981303,0.000047563557],"domain_scores_gemma":[0.9988153,0.00025433596,0.0005082953,0.000076884615,0.00011310871,0.00023203665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054909673,0.00015711894,0.00018916161,0.00040231546,0.00025354262,0.0005060739,0.00019795324,0.00019001069,0.0016633073],"category_scores_gemma":[0.0015952353,0.00008666899,0.0004266916,0.0004755197,0.00025501373,0.0003251251,0.0003561898,0.0003045105,0.00020336879],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006166922,0.0000063313482,0.99915075,0.000003850612,0.000024678007,0.000036819634,0.00001688126,0.000022427213,0.00011455437,0.000007022427,0.000022447199,0.00053254067],"study_design_scores_gemma":[0.0000017829256,0.000052997177,0.9992071,0.000004092171,0.000029545796,0.0001956091,0.00013262927,0.00016576005,0.00009527972,0.000024749423,0.00008882741,0.0000016783558],"about_ca_topic_score_codex":0.0030515797,"about_ca_topic_score_gemma":0.0052145324,"teacher_disagreement_score":0.0030515797,"about_ca_system_score_codex":0.00018719584,"about_ca_system_score_gemma":0.0002689617,"threshold_uncertainty_score":0.0060676336},"labels":[],"label_agreement":null},{"id":"W2979495016","doi":"","title":"Community-Based Participatory Research in cancer control studies among Indigenous people of Australia, New Zealand, Canada and the US","year":2010,"lang":"en","type":"article","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Qualitative Research Methods and Ethics","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Indigenous; Participatory action research; Community-based participatory research; Citizen journalism; Geography; Socioeconomics; Control (management); Sociology; Environmental planning; Political science; Anthropology; Ecology; Economics; Management; Biology","score_opus":0.6888879500146597,"score_gpt":0.6759645624976514,"score_spread":0.012923387517008389,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979495016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97149277,0.0020087135,0.004798833,0.003771334,0.000121487894,0.0100843,0.00007819097,0.00001892837,0.007625475],"genre_scores_gemma":[0.9894889,0.0005711343,0.0039653694,0.00040197853,0.000019753043,0.0046860357,0.000019701945,0.000004588366,0.0008425285],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9409569,0.05095614,0.0013821576,0.0012845204,0.0025177754,0.0029025234],"domain_scores_gemma":[0.9184334,0.06592257,0.003045668,0.0020434663,0.005433826,0.0051210634],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.08078338,0.00050575583,0.00091055874,0.0022428788,0.016138777,0.0034545527,0.002559731,0.0016580882,0.0025709951],"category_scores_gemma":[0.07689516,0.0007401688,0.00044908246,0.0023026702,0.008992807,0.0018351148,0.0058015725,0.0020497015,0.000094512805],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035899918,0.0008520898,0.0140563855,0.0011683911,0.00006542174,0.000325865,0.9531463,0.0001702823,0.0007509762,0.0030791063,0.0005446329,0.025481522],"study_design_scores_gemma":[0.00058435986,0.0010398467,0.029764079,0.0017745437,0.00016247512,0.00022520078,0.9513476,0.00066450326,0.00071742985,0.0044573727,0.009210308,0.00005227401],"about_ca_topic_score_codex":0.28827134,"about_ca_topic_score_gemma":0.39872554,"teacher_disagreement_score":0.91921663,"about_ca_system_score_codex":0.013687579,"about_ca_system_score_gemma":0.06630508,"threshold_uncertainty_score":0.5731868},"labels":[],"label_agreement":null},{"id":"W3086232680","doi":"10.1111/ajco.13430","title":"Awareness of and preference for disease prognosis and participation in treatment decisions among advanced cancer patients in Myanmar: Results from the APPROACH study","year":2020,"lang":"en","type":"article","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Preference; Medicine; Disease; Descriptive statistics; Logistic regression; Cancer; Family medicine; Quarter (Canadian coin); Stage (stratigraphy); Internal medicine","score_opus":0.5958672120227494,"score_gpt":0.57180087968167,"score_spread":0.024066332341079355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3086232680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996941,0.0000374188,0.000010646005,0.000059244758,0.0000010514767,0.0000033549848,0.000036228274,2.7463622e-7,0.00015770001],"genre_scores_gemma":[0.9997527,0.000047339316,0.000016996659,0.00003215485,0.0000022095078,0.000006248304,0.00003946245,2.1146167e-7,0.000102651655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99976236,0.00010390252,0.000018273751,0.000021729442,0.000029702609,0.00006416332],"domain_scores_gemma":[0.99930465,0.00015576326,0.00033276874,0.000025517536,0.00005862709,0.00012273299],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004467985,0.0001210786,0.00012997628,0.0002535252,0.00039923517,0.0003665651,0.00014563659,0.00024264799,0.00212802],"category_scores_gemma":[0.0017403308,0.000118498014,0.00025193056,0.00029600394,0.00016353361,0.00033266484,0.00043159735,0.00043362656,0.00018260865],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056638182,0.00010795438,0.9951534,0.000014924914,0.000020542493,0.00004959911,0.0018945733,0.000015718484,0.00010594846,0.000015839998,0.00013992,0.0024249658],"study_design_scores_gemma":[0.000007679428,0.00012947497,0.9963433,0.0000119259785,0.000013006299,0.00009752753,0.0029958473,0.00009124553,0.000026340156,0.000010175723,0.00027061702,0.0000029148348],"about_ca_topic_score_codex":0.0073039704,"about_ca_topic_score_gemma":0.008998193,"teacher_disagreement_score":0.0073039704,"about_ca_system_score_codex":0.0003075759,"about_ca_system_score_gemma":0.0003829421,"threshold_uncertainty_score":0.01452291},"labels":[],"label_agreement":null},{"id":"W3092156640","doi":"10.1111/ajco.13482","title":"Changes in DNA methylation after 6‐week exercise training in colorectal cancer survivors: A preliminary study","year":2020,"lang":"en","type":"article","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging; University of Alberta","funders":"","keywords":"Epigenetics; DNA methylation; Colorectal cancer; Randomized controlled trial; Medicine; CpG site; Methylation; Disease; Oncology; Cancer; Internal medicine; Bioinformatics; Gene; Biology; Genetics; Gene expression","score_opus":0.08415892557546056,"score_gpt":0.3946346349472204,"score_spread":0.31047570937175983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092156640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99763215,0.000980878,0.00026185124,0.000055151293,0.000020275158,0.0006807913,0.0001559603,0.000008508759,0.0002045039],"genre_scores_gemma":[0.995884,0.0010266214,0.0010169714,0.00016946775,0.000055393877,0.0010066264,0.0004170308,0.000003253059,0.00042060114],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9993611,0.00033901073,0.000063570566,0.00008303629,0.00008389707,0.00006941025],"domain_scores_gemma":[0.9990421,0.00029725046,0.00018281747,0.00010418354,0.00014877378,0.00022487449],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017921807,0.00040083646,0.0007772053,0.00027266573,0.00038066052,0.00018558835,0.0002834782,0.00049441966,0.0019230528],"category_scores_gemma":[0.0016443604,0.00017615728,0.00084541895,0.00039825027,0.00032027753,0.00020450946,0.00029151037,0.00043630984,0.0002030398],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.47888023,0.08261957,0.19935039,0.0038055638,0.002939421,0.00033478427,0.001044396,0.00069571607,0.055914953,0.00006951052,0.0007540419,0.17359136],"study_design_scores_gemma":[0.019020809,0.53132576,0.44032952,0.00012811233,0.0022468155,0.00015207767,0.00020649067,0.00026448583,0.0046925824,0.0000377813,0.0015731538,0.000022535278],"about_ca_topic_score_codex":0.002051658,"about_ca_topic_score_gemma":0.0029416364,"teacher_disagreement_score":0.002051658,"about_ca_system_score_codex":0.0002201781,"about_ca_system_score_gemma":0.00086739194,"threshold_uncertainty_score":0.009478033},"labels":[],"label_agreement":null},{"id":"W3129179205","doi":"10.1111/ajco.13508","title":"Measuring financial toxicity in Australian cancer patients – Validation of the COmprehensive Score for financial Toxicity (FACT COST) measuring financial toxicity in Australian cancer patients","year":2021,"lang":"en","type":"article","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Quality of life (healthcare); Population; Cronbach's alpha; Anxiety; Depression (economics); Finance; Psychiatry; Environmental health; Psychometrics; Clinical psychology; Business; Nursing","score_opus":0.18885358239192773,"score_gpt":0.363324292670727,"score_spread":0.1744707102787993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129179205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99732363,0.00021706878,0.0004105887,0.0001094101,0.000011484241,0.00022158261,0.00027342082,0.000003745572,0.0014290564],"genre_scores_gemma":[0.9969831,0.00016168284,0.0016487922,0.00008626243,0.000014056005,0.0003038465,0.0004480638,0.0000022494519,0.00035194145],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996738,0.0016323287,0.0004882726,0.00016271087,0.0007906332,0.00018810066],"domain_scores_gemma":[0.99294406,0.0014159433,0.0029051853,0.00031051537,0.0019510975,0.00047313207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0053732153,0.0003182798,0.0005034253,0.0013766289,0.000629662,0.0007780975,0.00056193676,0.0005785095,0.0012635407],"category_scores_gemma":[0.013247135,0.00024724277,0.00087196735,0.0013995923,0.0004893594,0.00057231577,0.0013170155,0.00075870694,0.00022513237],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037757654,0.0003729585,0.9764332,0.00014378568,0.00014823454,0.00013309727,0.0012202241,0.00039211905,0.00043632425,0.00010461021,0.00062840513,0.019609405],"study_design_scores_gemma":[0.000026051917,0.00053691387,0.9972703,0.00003127476,0.000035115176,0.00024231388,0.00032998808,0.0006393104,0.00012956577,0.000059713042,0.00069142616,0.000007986356],"about_ca_topic_score_codex":0.0053305393,"about_ca_topic_score_gemma":0.007773468,"teacher_disagreement_score":0.0053732153,"about_ca_system_score_codex":0.001095679,"about_ca_system_score_gemma":0.0008205062,"threshold_uncertainty_score":0.028416574},"labels":[],"label_agreement":null},{"id":"W3133211858","doi":"10.1111/ajco.13544","title":"Australia and New Zealand's responsibilities in improving oncology services in the Asia‐Pacific: A call to action","year":2021,"lang":"en","type":"review","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Global Health and Surgery","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Call to action; Capacity building; Health care; Government (linguistics); Leverage (statistics); Public relations; Political science; Asia pacific; Business; Medicine; Marketing","score_opus":0.26987108053041253,"score_gpt":0.5416084245857075,"score_spread":0.2717373440552949,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3133211858","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027760349,0.02154322,0.0009771215,0.95865655,0.009661831,0.00012138262,0.00012579831,0.000121120116,0.0060169953],"genre_scores_gemma":[0.13437149,0.10144276,0.035610527,0.68821645,0.008338326,0.0010660904,0.0006088987,0.00033860333,0.030006902],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98310626,0.0065510785,0.0015207133,0.0011161494,0.0040309518,0.0036748745],"domain_scores_gemma":[0.92217034,0.011836654,0.004197629,0.002354852,0.016686676,0.042753868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.031531733,0.0011720301,0.0016965057,0.0014144395,0.004978867,0.007900307,0.0041244836,0.01744434,0.013729905],"category_scores_gemma":[0.042450856,0.0010317252,0.0030398434,0.0018120997,0.008043408,0.013895653,0.015818251,0.01907145,0.0017901643],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017111657,0.00025755417,0.008430698,0.006119198,0.00026081986,0.0015146714,0.013005752,0.0007087933,0.0015245404,0.019666756,0.7832115,0.16512862],"study_design_scores_gemma":[0.000118367556,0.00024142583,0.019856498,0.004324186,0.00012127989,0.0007015089,0.016575273,0.00045171866,0.00031800507,0.008052015,0.94908154,0.00015816702],"about_ca_topic_score_codex":0.22499569,"about_ca_topic_score_gemma":0.2154469,"teacher_disagreement_score":0.22499569,"about_ca_system_score_codex":0.013474132,"about_ca_system_score_gemma":0.13426656,"threshold_uncertainty_score":0.44737208},"labels":[],"label_agreement":null},{"id":"W3173244755","doi":"10.1111/ajco.13595","title":"<sup>68</sup>Ga‐prostate‐specific membrane antigen (PSMA) PET/CT as a clinical decision‐making tool in biochemically recurrent prostate cancer","year":2021,"lang":"en","type":"article","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Sanofi; AstraZeneca; Pfizer; Astellas Pharma; Bristol-Myers Squibb","keywords":"Medicine; Watchful waiting; Prostate cancer; Biochemical recurrence; Logistic regression; Radiation therapy; Prostate; Radiology; Nuclear medicine; Urology; Internal medicine; Cancer; Prostatectomy","score_opus":0.09134584371318756,"score_gpt":0.4848521792671509,"score_spread":0.39350633555396336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3173244755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986455,0.0006165732,0.00020457715,0.000097296965,0.000004767956,0.000009027184,0.000039815906,0.0000058071387,0.00037670313],"genre_scores_gemma":[0.99956304,0.00010239247,0.00021370668,0.000016047547,0.0000109848515,0.0000034699694,0.000037566275,9.2107746e-7,0.00005183592],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99951434,0.00030115864,0.000037893456,0.000028318942,0.00006997432,0.000048346436],"domain_scores_gemma":[0.99855345,0.0007786036,0.00037301556,0.000037222293,0.00009256835,0.00016501399],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015904111,0.0002311227,0.00021875165,0.0005444229,0.00015138899,0.0006888539,0.00026111313,0.00020318292,0.000857792],"category_scores_gemma":[0.0033006428,0.0002036892,0.000202004,0.00033730778,0.00035493274,0.0003080457,0.00023297852,0.00029302872,0.00022856398],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010495794,0.00006425475,0.9816218,0.000028581722,0.00002738173,0.00041790056,0.00007623159,0.0004077532,0.0011540905,0.000019975592,0.00023672123,0.014895774],"study_design_scores_gemma":[0.000040461946,0.0007572141,0.9866658,0.00003345034,0.00007314836,0.0021782948,0.00020404081,0.007852975,0.0016858712,0.000078553036,0.0004210779,0.000009079422],"about_ca_topic_score_codex":0.002198419,"about_ca_topic_score_gemma":0.0041981433,"teacher_disagreement_score":0.002198419,"about_ca_system_score_codex":0.0004419827,"about_ca_system_score_gemma":0.00037040675,"threshold_uncertainty_score":0.00841105},"labels":[],"label_agreement":null},{"id":"W3214836900","doi":"10.1111/ajco.13700","title":"Poster Abstracts","year":2021,"lang":"en","type":"article","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"Medical Research Council; Australian and New Zealand Urogenital and Prostate Cancer Trials Group; National Health and Medical Research Council; Peter MacCallum Cancer Centre; University of Melbourne","keywords":"Citation; Library science; Computer science; Information retrieval; World Wide Web","score_opus":0.09283884681477143,"score_gpt":0.4456423787686756,"score_spread":0.3528035319539041,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214836900","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004596186,0.15597966,0.0059772027,0.14525004,0.33131906,0.010527403,0.03569926,0.0010954475,0.3095558],"genre_scores_gemma":[0.052621853,0.1664547,0.012059444,0.112762876,0.23940215,0.012228861,0.026582988,0.0009918271,0.37689525],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99648833,0.0012983654,0.0004758433,0.00036471302,0.0010604573,0.00031224012],"domain_scores_gemma":[0.9852035,0.0039210604,0.0016586753,0.0005368762,0.0059480304,0.0027317828],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0083128335,0.0012897121,0.0011486044,0.0028568872,0.0011112521,0.0044216327,0.0017416965,0.0029103665,0.42857906],"category_scores_gemma":[0.02989527,0.00043137855,0.002534699,0.0016671116,0.00062110473,0.0023490575,0.0030603034,0.0032420026,0.11455132],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095803343,0.00007743748,0.00027339556,0.013776717,0.00013224644,0.00007786008,0.00008507868,0.00009843469,0.00030357635,0.0015112066,0.8711473,0.111558706],"study_design_scores_gemma":[0.00075244583,0.00036771334,0.0015899661,0.020851964,0.00036818898,0.0002359856,0.00035437473,0.00009619474,0.0005038355,0.004413747,0.9704302,0.000035476864],"about_ca_topic_score_codex":0.0010535376,"about_ca_topic_score_gemma":0.0017945896,"teacher_disagreement_score":0.5714209,"about_ca_system_score_codex":0.0018083164,"about_ca_system_score_gemma":0.005833749,"threshold_uncertainty_score":0.81506264},"labels":[],"label_agreement":null},{"id":"W4239232225","doi":"10.1111/ajco.12301","title":"International Speakers","year":2014,"lang":"en","type":"article","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Complementary and Alternative Medicine Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"European Society for Medical Oncology; Monash University; Memorial Sloan-Kettering Cancer Center","keywords":"Linguistics; Psychology; Philosophy","score_opus":0.13853237616482456,"score_gpt":0.49714733523764176,"score_spread":0.3586149590728172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239232225","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018549005,0.009431945,0.0014577238,0.08711712,0.35543713,0.0003562744,0.0019893423,0.0009774537,0.5413781],"genre_scores_gemma":[0.008343032,0.003440116,0.0005897275,0.010577776,0.048946954,0.00019537186,0.00092472363,0.00043871178,0.9265436],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978235,0.00025155753,0.00009947695,0.0003044607,0.0010383698,0.00048279777],"domain_scores_gemma":[0.9874378,0.0007853406,0.00041266897,0.00035484886,0.006205621,0.0048036217],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003183579,0.0014538994,0.00077189395,0.0019552854,0.0022597646,0.0052471827,0.0012857695,0.0025673062,0.48861745],"category_scores_gemma":[0.011877585,0.0003141084,0.00059805484,0.00096209935,0.0006293902,0.0024860506,0.0034749547,0.0032442391,0.26245946],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037803096,0.000015310978,0.00008122674,0.00006225607,0.0000013309328,0.000068332556,0.00007530975,0.000017704931,0.00025566798,0.0020125029,0.9681416,0.029230937],"study_design_scores_gemma":[0.0000064926317,0.000012021145,0.00026542813,0.000055657776,0.0000012822479,0.00008479541,0.0001339856,0.000026985175,0.00007553902,0.0004910215,0.99884367,0.000003092035],"about_ca_topic_score_codex":0.0010366741,"about_ca_topic_score_gemma":0.0019121378,"teacher_disagreement_score":0.48861745,"about_ca_system_score_codex":0.0015066025,"about_ca_system_score_gemma":0.0025293794,"threshold_uncertainty_score":0.72942513},"labels":[],"label_agreement":null},{"id":"W4295992489","doi":"10.1111/ajco.12029","title":"Oral Abstracts","year":2012,"lang":"en","type":"article","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of Calgary; Baker Hughes (Canada); Alberta Health Services","funders":"Clinical Oncological Society of Australia; National Health Research Institutes; Sanofi","keywords":"Exhibition; Convention; Citation; Library science; Medicine; Political science; Psychology; History; Law; Computer science; Art history","score_opus":0.1403806078892433,"score_gpt":0.48173004100176114,"score_spread":0.34134943311251786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295992489","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0046039773,0.017420491,0.002800454,0.056068793,0.24165337,0.0052500847,0.032977317,0.0014368574,0.6377888],"genre_scores_gemma":[0.011942552,0.009566742,0.002307041,0.017957099,0.035975937,0.0035207793,0.008971692,0.0005820474,0.9091761],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99894756,0.00016492569,0.000107035754,0.00010410337,0.0005601463,0.00011620606],"domain_scores_gemma":[0.99634475,0.00065825245,0.00022041926,0.0003541381,0.0018164068,0.00060603366],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0019954427,0.0007487126,0.00072819996,0.0012557439,0.0017064486,0.0034932985,0.0011281976,0.0023485892,0.6171321],"category_scores_gemma":[0.010602369,0.00025389215,0.0011810316,0.00085126865,0.0004039655,0.0012610093,0.0019512818,0.0019062416,0.2211447],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018725092,0.00004601608,0.000061993494,0.0005801778,0.0000075858675,0.000049656646,0.000041463496,0.000015322734,0.00018558122,0.0007376211,0.95232964,0.04575773],"study_design_scores_gemma":[0.00014428103,0.00007626686,0.0006658559,0.0007365849,0.000018212319,0.000112091664,0.0001736661,0.00002190793,0.00030912156,0.0010409245,0.9966903,0.000010831342],"about_ca_topic_score_codex":0.002649083,"about_ca_topic_score_gemma":0.004430994,"teacher_disagreement_score":0.38286787,"about_ca_system_score_codex":0.0013230828,"about_ca_system_score_gemma":0.0028981282,"threshold_uncertainty_score":0.54611456},"labels":[],"label_agreement":null},{"id":"W4307496993","doi":"10.1111/ajco.13886","title":"Early phase oncology clinical trials in Malaysia: current status and future perspectives","year":2022,"lang":"en","type":"review","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Clinical trial; Drug development; Facilitator; Government (linguistics); Enabling; Clinical Oncology; Medicine; Oncology; Political science; Business; Economic growth; Internal medicine; Pharmacology; Drug; Cancer","score_opus":0.20695682958226733,"score_gpt":0.5511819430023001,"score_spread":0.3442251134200327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307496993","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014932003,0.99815637,0.00007192988,0.0009842423,0.00015072814,0.0000050383974,0.000012146296,0.0000051849947,0.00046512982],"genre_scores_gemma":[0.0013533533,0.99778557,0.00013097866,0.0003907978,0.00013955723,0.000008287356,0.000018802803,0.0000013493869,0.00017117264],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99869424,0.0004755469,0.00022306637,0.00015127276,0.00031279764,0.0001431131],"domain_scores_gemma":[0.9930561,0.0039295945,0.0010374761,0.00012255964,0.0012627601,0.0005915357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0053459606,0.00086422235,0.0013393858,0.002055251,0.0003475066,0.002397261,0.0014648492,0.0020411604,0.0038312695],"category_scores_gemma":[0.0061039343,0.000380948,0.0009117203,0.002849246,0.0011006409,0.0032718533,0.0010695772,0.002641237,0.0009759886],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018856091,0.00010246601,0.00063733454,0.023082145,0.0000817758,0.00017674746,0.00010307111,0.0007179032,0.00039598183,0.0051154406,0.021064695,0.9483339],"study_design_scores_gemma":[0.00009887293,0.00050671893,0.0028955415,0.028160492,0.00031338827,0.0020864736,0.0002979961,0.00042095623,0.00077680487,0.004111091,0.96027464,0.00005711215],"about_ca_topic_score_codex":0.002360579,"about_ca_topic_score_gemma":0.0056774807,"teacher_disagreement_score":0.0053459606,"about_ca_system_score_codex":0.001883842,"about_ca_system_score_gemma":0.0058275987,"threshold_uncertainty_score":0.02827245},"labels":[],"label_agreement":null},{"id":"W4375950762","doi":"10.1111/ajco.13953","title":"18F‐FMISO PET‐guided dose escalation with multifield optimization intensity‐modulated proton therapy in nasopharyngeal carcinoma","year":2023,"lang":"en","type":"article","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Radiation Therapy and Dosimetry","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Medical Research Council; Medical Research Council; Terry Fox Foundation; National Cancer Centre of Singapore","keywords":"Nuclear medicine; Medicine; Radiation therapy; Proton therapy; Positron emission tomography; Radiation treatment planning; Tumor hypoxia; Standardized uptake value; Radiology","score_opus":0.08901909957813778,"score_gpt":0.4094858639795292,"score_spread":0.32046676440139144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4375950762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950223,0.00042588476,0.0040461933,0.00003134047,0.0000038085698,0.000048291087,0.00002905311,0.00003412725,0.00035890416],"genre_scores_gemma":[0.99443024,0.00012844506,0.0050590723,0.000015354157,0.0000052233163,0.00004364034,0.000046143436,0.000013494776,0.00025835674],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998864,0.000031610187,0.0000066868456,0.000019556135,0.000042514534,0.0000131871175],"domain_scores_gemma":[0.99994147,0.000017084478,0.000016524862,0.00001147803,0.000006142294,0.0000072327607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030959997,0.00016505727,0.0001947875,0.00016816941,0.00017127013,0.00016002206,0.00033892872,0.00016455079,0.0005416346],"category_scores_gemma":[0.00040061527,0.00012090439,0.00022366915,0.00012144515,0.00022651232,0.00013768142,0.00017052269,0.0001641759,0.00010358816],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049191,0.0015138569,0.07311573,0.0004841638,0.0001874161,0.00069784635,0.0005835317,0.085216895,0.51756114,0.00040036623,0.0006428212,0.31467712],"study_design_scores_gemma":[0.0018704564,0.021642288,0.43082088,0.00005821288,0.00030206743,0.0045408634,0.0003009842,0.10883188,0.42231372,0.0012823672,0.007961362,0.00007483513],"about_ca_topic_score_codex":0.0021056721,"about_ca_topic_score_gemma":0.0025203282,"teacher_disagreement_score":0.0021056721,"about_ca_system_score_codex":0.0006207796,"about_ca_system_score_gemma":0.00030860276,"threshold_uncertainty_score":0.0045040846},"labels":[],"label_agreement":null},{"id":"W4387296889","doi":"10.1111/ajco.14030","title":"Re‐re‐biopsy? How much tumor is enough in the era of precision oncology?","year":2023,"lang":"en","type":"editorial","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Liquid biopsy; Erlotinib; Afatinib; Medicine; Precision medicine; Gefitinib; Cancer research; Lung cancer; Personalized medicine; Epidermal growth factor receptor; Targeted therapy; Oncology; Mutation; Biopsy; ROS1; Internal medicine; Cancer; Gene; Pathology; Bioinformatics; Adenocarcinoma; Biology; Genetics","score_opus":0.07119682710064731,"score_gpt":0.49022388508803566,"score_spread":0.4190270579873884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387296889","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007184,0.43403125,0.016823715,0.51335865,0.019795401,0.00008214822,0.000318399,0.00040921857,0.007997229],"genre_scores_gemma":[0.1628226,0.40881997,0.03656647,0.31134245,0.06859366,0.00026913112,0.000900241,0.0009013362,0.009784169],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9945357,0.002509891,0.000525528,0.00073026674,0.0013451978,0.0003534506],"domain_scores_gemma":[0.96779835,0.018386103,0.002253773,0.0021608237,0.0067119207,0.0026890154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017074855,0.0007468947,0.0025004821,0.0014962914,0.0015615209,0.0057865526,0.0021261717,0.005484461,0.0069562388],"category_scores_gemma":[0.045573127,0.0005796327,0.0010446591,0.0009809779,0.006403202,0.016683452,0.0019680387,0.009310625,0.0052566463],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072418764,0.00009637513,0.008836288,0.0033932058,0.00028576015,0.0016842517,0.0008481445,0.0005993752,0.002566139,0.01849129,0.24841437,0.7140606],"study_design_scores_gemma":[0.00012262874,0.0004614224,0.0071405466,0.010876321,0.00049866823,0.017851025,0.0052281967,0.0016701377,0.0028218736,0.116484955,0.8365523,0.0002918615],"about_ca_topic_score_codex":0.0027887658,"about_ca_topic_score_gemma":0.0050968938,"teacher_disagreement_score":0.017074855,"about_ca_system_score_codex":0.0031298522,"about_ca_system_score_gemma":0.002608069,"threshold_uncertainty_score":0.09030151},"labels":[],"label_agreement":null},{"id":"W4394873139","doi":"10.1111/ajco.14064","title":"Management of advanced prostate cancer in the Asia‐Pacific region: Summary of the Asia‐Pacific Advanced Prostate Cancer Consensus Conference 2023","year":2024,"lang":"en","type":"article","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Astellas Pharma Canada; Bayer; AstraZeneca; Pfizer","keywords":"Prostate cancer; Consensus conference; Reimbursement; Asia pacific; Medicine; Cancer; Political science; Gynecology; Internal medicine; Business; Health care","score_opus":0.08370714508975953,"score_gpt":0.4454766813636823,"score_spread":0.3617695362739228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394873139","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0051674913,0.37454426,0.015958572,0.49176264,0.0608384,0.0019612976,0.0038484791,0.00037657018,0.045542303],"genre_scores_gemma":[0.06535159,0.63531023,0.064957865,0.13844362,0.036653906,0.005187763,0.02219526,0.0003862462,0.031513587],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9907823,0.0031258217,0.0013253996,0.00040172183,0.003445609,0.0009191331],"domain_scores_gemma":[0.9819727,0.0018667958,0.0011819704,0.00021772864,0.012225836,0.002534935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02508099,0.0013407245,0.0014335649,0.0027984881,0.0013833889,0.0025948046,0.0031497828,0.0047276984,0.004613243],"category_scores_gemma":[0.016667502,0.0006636543,0.0028821744,0.0025122305,0.00069880387,0.002047514,0.0033115805,0.006326313,0.002124483],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011244657,0.000143256,0.0035792934,0.008235362,0.0001894371,0.00041618093,0.0005219832,0.0016423026,0.0007774327,0.003114974,0.68894994,0.29231745],"study_design_scores_gemma":[0.000077978664,0.00014396932,0.008584262,0.017749414,0.00026215223,0.0010579895,0.0009589391,0.000808203,0.0005806769,0.0038245243,0.96585774,0.00009408562],"about_ca_topic_score_codex":0.015429867,"about_ca_topic_score_gemma":0.019078963,"teacher_disagreement_score":0.02508099,"about_ca_system_score_codex":0.004788754,"about_ca_system_score_gemma":0.028439168,"threshold_uncertainty_score":0.13264257},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"other","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"gpt","categories":[],"domain":null,"study_design":"not_applicable","genre":"commentary","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"agree"}]}